Aspen corporate brochure

Corporate Brochure November 2013

Issue link:

Contents of this Issue


Page 1 of 23

Innovation We constantly search for better ways of doing things, and are solution orientated (Entrepreneurship, Flexibility, Adaptability) Commitment We go the extra mile, seeking to exceed expectations (Passion, Dedication, Loyalty, Responsibility, Accountability) About Aspen WHO WE ARE Aspen is a global supplier of branded and generic pharmaceutical products as well as consumer and nutritional products in selected territories. The Group has a proud heritage dating back more than 160 years and today its products reach approximately 150 countries. Aspen is the largest pharmaceutical company listed on the JSE Limited ("JSE"), South Africa's stock exchange. Aspen had a market capitalisation of R103,5 billion (approximately USD10 billion) as at 30 June 2013. It is ranked among the top 10 generic pharmaceutical producers globally. The Group has delivered sustained growth for 15 consecutive years with a CAGR in revenue, operating profit and normalised diluted headline earnings exceeding 40% for this period. Aspen has a strong and growing footprint in emerging markets. The largest pharmaceutical company in Africa, Aspen has an expanding presence in Latin America and South East Asia. Recently announced acquisitions will extend the Group's emerging market presence to the Commonwealth of Independent States ("CIS"), comprising Russia and the former Soviet Republics as well as to Central and Eastern Europe ("CEE"). Aspen is one of the leading pharmaceutical companies in Australia, and is beginning to establish a presence in other developed markets. Following the acquisition of the active pharmaceutical ingredient ("API") manufacturing sites in the Netherlands and the United States on 1 October 2013, the Group now has 22 manufacturing facilities at 16 pharmaceutical manufacturing sites on six continents and approximately 8 200 employees. We strive to be the best we can be and to deliver to the highest standards Excellence (Diligence, Quality) ASPEN'S STRATEGIC PRIORITIES ASPEN'S STRATEGIC PRIORITIES The Group's strategic direction is determined The Group's under the guidance determined by our visionstrategic direction is of our values. by our vision under the guidance of our values. Delivering value to shareholders Responsible corporate citizen Providing high quality, affordable products To deliver sustainable growth in earnings from a diversified portfolio of products and geographies To provide a safe, challenging To provide a safe, challenging and rewarding environment for and rewarding environment for our employees our employees To supply customers and patients with high quality medicines at competitive prices To achieve a strategic advantage through our production capabilities To practise good To corporate citizenship practise good orporate c citizenship To achieve superior returns on investment for our shareholders over the long term To increase the direct promotion of Aspen products worldwide To continuously increase and improve our offering to healthcare professionals and patients through a prolific product pipeline To be alert to opportunities to enhance the value of the Group for its stakeholders VALUES: Commitment, Excellence, Innovation, Integrity and Teamwork Commitment, Excellence, Innovation, Integrity and Teamwork WHAT WE DO Our vision is to deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally. Aspen provides an extensive basket of products which enable the treatment of a broad spectrum of acute and chronic conditions experienced throughout all stages of life. The Group is committed to increasing access to healthcare by delivering on our vision.

Articles in this issue

view archives of Aspen corporate brochure - Corporate Brochure November 2013